- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Novo Nordisk A/S
Total 1552 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Switzerland
-
Novo Nordisk A/SEnrolling by invitationHaemophilia BNetherlands, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of
-
Novo Nordisk A/SCompletedHealthy Volunteers (Diabetes Mellitus, Type 2)United Kingdom
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States
-
Novo Nordisk A/SActive, not recruitingChronic Kidney Disease and Systemic InflammationChina
-
Novo Nordisk A/SCompletedHealthy Volunteers | Atherosclerotic Cardiovascular DiseaseJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, South Africa, Russian Federation, Former Serbia and Montenegro, North Macedonia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Slovakia, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Chronic Kidney Disease
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesUnited Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFrance
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSpain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, France
-
Novo Nordisk A/STerminated
-
Novo Nordisk A/SCompletedNoonan Syndrome | Genetic DisorderSweden
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderFrance, United States, Turkey, Italy, Australia, New Zealand, Canada, Netherlands
-
Novo Nordisk A/SEnrolling by invitationObesity | OverweightUnited States, Saudi Arabia, Brazil, Canada, Spain
-
Novo Nordisk A/SCompletedChronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)India
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Greece, Japan, Bulgaria, Slovakia, Ukraine, Czechia
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderItaly, Germany
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1Austria